Inpefa (sotagliflozin) / Lexicon Pharma  >>  Phase 4
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Inpefa (sotagliflozin) / Lexicon Pharma
NCT05562063: Sotagliflozin in Heart Failure With Preserved Ejection Fraction (HFpEF) Patients

Recruiting
4
60
US
Sotagliflozin, Placebo
Juan Badimon
Heart Failure With Preserved Ejection Fraction
11/25
11/25
PLUTO, NCT06147232: Prevention of Chronic Kidney Disease(CDK) Progression in Type 1 Diabetes With Long Term Use of Sodium-Glucose-coTransporter Inhibitors Avoiding Kidney hypOxia

Not yet recruiting
4
69
Europe
Sotagliflozin, Inpefa (TM), Placebo
Steno Diabetes Center Copenhagen, Juvenile Diabetes Research Foundation, King's College London, Glostrup University Hospital, Copenhagen
Nephropathy, Diabetic Nephropathies, Diabetes Mellitus, Type 1, Albuminuria, Diabetic Complications Renal, Diabetic Complications Cardiovascular, Hypoxia
06/26
06/36

Download Options